Artificial intelligence and data integration to achieve improved outcomes and personalised healthcare in IBD KU Leuven
Inflammatory bowel diseases are complex diseases resulting from the combination of multiple etiological factors, and present major challenges in diagnosis, classification and management. Current treatment strategies are applied in an indiscriminate fashion, though anti-inflammatory drugs only benefit a limited number of patients (ceiling of 30-40%) and therefore leaving large margins for improvement. This “one measure does not fit all” ...